An internal standard for the quantification of aspirin
Related Products
Unlabeled Version(s)
70260Aspirin
Technical Support & Resources

Visit our FAQ

Contact Us

Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888

Request Technical Support

Technical Support Request

To streamline the process attach the appropriate questionnaire to your inquiry.

Download IHC QuestionnaireDownload WB Questionnaire

View Our Privacy Statement for details on how we use and protect your data. In addition, this site is protected by hCaptcha and its Privacy Policy and Terms of Service apply.

Aspirin-d4

Item No. 18243

Technical Information
Formal Name
6-(acetyloxy)-benzoic-2,3,4,5-d4 acid
CAS Number
97781-16-3
Synonyms
  • Acetylsalicylic Acid-d4
Molecular Formula
C9H4D4O4
Formula Weight
Purity
≥95%
Formulation
A crystalline solid
DMF: > 30 mg/mlDMSO: > 41 mg/mlEthanol: > 80 mg/mlPBS (pH 7.2): > 2.7 mg/ml
λmax
225 nm
SMILES
OC(C1=C(OC(C)=O)C([2H])=C([2H])C([2H])=C1[2H])=O
InChi Code
InChI=1S/C9H8O4/c1-6(10)13-8-5-3-2-4-7(8)9(11)12/h2-5H,1H3,(H,11,12)/i2D,3D,4D,5D
InChi Key
BSYNRYMUTXBXSQ-QFFDRWTDSA-N
Shipping & Storage Information
Storage
-20°C
Shipping
Room temperature in continental US; may vary elsewhere
Recommended Products

Certificates of Analysis & Batch Specific Data

Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

    Add

    Add

    Add

    Lipid Resource Center
    Discover Products & Resources for Lipid Research
    • High-purity lipid standards
    • Lipid roles in biology
    • Lipids in health & disease
    • Lipids for pharmaceutical development
    • Protocols, advice, & resources
    EXPLORE NOW
    Product Description

    Aspirin-d4 is intended for use as an internal standard for the quantification of aspirin (Item No. 70260) by GC- or LC-MS. Aspirin is a non-steroidal anti-inflammatory drug (NSAID) and a covalent inhibitor of COX-1 and COX-2 (IC50s = 4.45 and 13.88 µM, respectively, for the human enzymes).1 It is also an inhibitor of hematopoietic prostaglandin D synthase (H-PGDS; IC50 = 750 µM for the ovine enzyme).2 Aspirin (6 µg/ml) inhibits epinephrine- and ADP-induced platelet aggregation.3 In vivo, aspirin (30 mg/kg) reduces infarct volume and microglial infiltration in a rat model of ischemia-reperfusion injury induced by middle cerebral artery occlusion (MCAO).4 It decreases macrophage infiltration into, increases the number of smooth muscle cells and levels of collagen in, and reduces the area of, atherosclerotic lesions in LDL receptor-deficient mice fed a high-fat diet when administered in the drinking water at 30 mg/L.5 Formulations containing aspirin have been used in the treatment of pain, fever, and in stroke prevention.

    WARNING This product is not for human or veterinary use.

    References & Product Citations
    Product Description References

    1. Cryer, B., and Feldman, M. Cyclooxygenase-1 and cyclooxygenase-2 selectivity of widely used nonsteroidal anti-inflammatory drugs. Am. J. Med. 104(5), 413-421 (1998).

    2. Johnson, J.L., Wimsatt, J., Buckel, S.D., et alPurification and characterization of prostaglandin H synthase-2 from sheep placental cotyledons. Arch. Biochem. Biophys. 324(1), 26-34 (1995).

    3. Papp, J., Sandor, B., Vamos, Z., et alAntiplatelet effect of acetylsalicylic acid, metamizole and their combination - in vitro and in vivo comparisons. Clin. Hemorheol. Microcirc. 56(1), 1-12 (2014).

    4. Whitehead, S.N., Bayona, N.A., Cheng, G., et alEffects of triflusal and aspirin in a rat model of cerebral ischemia. Stroke 38(2), 381-387 (2007).

    5. Cyrus, T., Sung, S., Zhao, L., et alEffect of low-dose aspirin on vascular inflammation, plaque stability, and atherogenesis in low-density lipoprotein receptor-deficient mice. Circulation 106, 1282-1287 (2002).